Recent News

• 02.12.2026 - OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
• 02.12.2026 - OPKO Health to Report Fourth Quarter 2025 Financial Results on February 26
• 02.04.2026 - OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
• 02.04.2026 - OPKO Health and Entera Bio Expand Partnership to Advance First-in-Class Oral Long Acting PTH Tablet for Patients with Hypoparathyroidism
• 01.06.2026 - OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
• 01.06.2026 - OPKO Health to Participate in the 44th Annual J.P. Morgan Healthcare Conference
• 11.19.2025 - OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
• 11.19.2025 - OPKO Health to Participate in the Piper Sandler 37th Annual Healthcare Conference
• 10.29.2025 - OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results
• 10.29.2025 - OPKO Health Reports Third Quarter 2025 Business Highlights and Financial Results

Recent Filings

• 11.21.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.19.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.18.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.31.2025 - 4 Statement of changes in beneficial ownership of securities
• 10.29.2025 - EX-99.1 EX-99.1
• 10.29.2025 - 8-K Current report
• 10.29.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]